C
CASI Pharmaceuticals D
D
CASI
5.77000
USD
0.02
(0.35%)
مغلق
حجم التداول
685
الربح لكل سهم
0
العائد الربحي
0
P/E
-3
حجم السوق
89,210,299
المقالات
العنوان: CASI Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.